prescription drug costs

Juin 5, 2020 10:27AM

Environmental appraisals for new gene therapies may limit new drugs in Canada

Dr. Nigel Rawson, Mackenzie Moir

New clinical trials registered with Health Canada fell by more than 52 per cent.

Étiquettes:

new prescription drugs, prescription drug costs, pharmaceutical innovation, access to new drugs

Décembre 13, 2018 1:00AM

The Unintended Consequences of National Pharmacare Programs: The Experiences of Australia, New Zealand, and the UK

Kristina M.L. Acri, née Lybecker

Étiquettes:

pharmacare, pharmaceutical spending, universal drug coverage, prescription drug costs, prescription drug coverage

Décembre 11, 2018 11:47AM

Canada's free ride on U.S. drug development may end soon

Steven Globerman, Bacchus Barua

In a bid to get even steeper drug discounts, Health Canada recently proposed changes to our reference-pricing system.

Étiquettes:

cost of medicare, american drug prices, access to medicines, pharmaceutical costs, prescription drug costs, new prescription drugs

Janvier 19, 2018 1:56PM

Ottawa’s revisions to drug-pricing review board will delay or prevent access to new drugs

Dr. Nigel Rawson

Pharmaceutical manufacturers take on a significant investment risk to develop new drugs.

Étiquettes:

drug costs, prescription drug costs, Access to Drugs, patented drugs

Juillet 6, 2017 2:07PM

Ottawa’s proposed changes to review board will reduce access to prescription drugs

Dr. Nigel Rawson, Bacchus Barua

Delay or denial of access to life-saving drugs is a potential death sentence.

Étiquettes:

prescription drug prices, prescription drug costs, patented medicine, medications, biologics, generic prescription drugs, new prescription drugs, access to new medicine

Janvier 20, 2017 11:03AM

Correct diagnosis, incorrect prescription—The Fifth Estate’s segment on pharmaceutical costs

Bacchus Barua

Every province in Canada has a prescription drug insurance program for low-income and vulnerable citizens.

Étiquettes:

new prescription drugs, prescription drug costs, drug coverage, fair pharmacare, pharmaceutical, pharmaceutical costs, cbc

Novembre 26, 2007 2:00AM

Cost Burden of Prescription Drug Spending in Canada and the United States, 2007 Edition

Brett J. Skinner, Mark Rovere

Étiquettes:

prescription drugs, prescription drug spending, generic drugs, medicine costs, drug costs, prescription drug costs

Août 23, 2004 2:00AM

Generic Drugopoly: Why Non-patented Prescription Drugs Cost More in Canada than in the United States and Europe

Brett J. Skinner

Étiquettes:

prescription drugs, prescription drug prices, prescription drug costs, generic drugs, patented drugs, medication

Août 31, 2003 6:00PM

Briefing to the House of Commons Standing Committee on Health on Prescription Drugs

John R. Graham

Étiquettes:

prescription drugs, pharmaceutical industry, prescription drug costs, pharmaceutical costs

Formulaire de recherche

prescription drug costs

Environmental appraisals for new gene therapies may limit new drugs in Canada

The Unintended Consequences of National Pharmacare Programs: The Experiences of Australia, New Zealand, and the UK

Canada's free ride on U.S. drug development may end soon

Ottawa’s revisions to drug-pricing review board will delay or prevent access to new drugs

Ottawa’s proposed changes to review board will reduce access to prescription drugs

Correct diagnosis, incorrect prescription—The Fifth Estate’s segment on pharmaceutical costs

Cost Burden of Prescription Drug Spending in Canada and the United States, 2007 Edition

Generic Drugopoly: Why Non-patented Prescription Drugs Cost More in Canada than in the United States and Europe

Briefing to the House of Commons Standing Committee on Health on Prescription Drugs